We also noted a remarkable increase in AGR2 immunoreactivity in the original tumor of the pathological lymph node-positive patient (pN1, n = 20, P < 0.01, Fig. 2D) compared with the pathological lymph node-negative patient (pN0, n = 39). The gene discussed is AGR2; the disease is neoplasm.